Skip to main content
NAMS logo

NAMS

NewAmsterdam Pharma Co N.V.
$34.83 -0.34 (-0.97%) At close · Jul 2
Market Cap
$4.07B
Shares
116,903,979

Fails to deliver — shares from a trade that were not delivered to the buyer by the settlement date — published by the SEC twice a month. Persistent fails can reflect settlement problems or naked short selling.

Fails to Deliver History

Settlement Date Quantity Price Value
2026-06-10 35,709 $30.38 $1,084,839
2026-06-09 720 $30.95 $22,284
2026-06-02 8 $31.79 $254
2026-05-20 5,258 $33.72 $177,300
2026-05-19 28,626 $34.14 $977,292
2026-05-18 543 $35.44 $19,244
2026-05-15 45,865 $36.88 $1,691,501
2026-05-14 2,002 $37.75 $75,576
2026-05-13 1,121 $38.89 $43,596
2026-05-12 17,408 $39.59 $689,183
2026-05-11 7,585 $38.73 $293,767
2026-04-20 1,144 $34.68 $39,674
2026-04-17 1 $33.20 $33
2026-04-16 3 $34.01 $102
2026-04-15 6,498 $34.44 $223,791
2026-04-14 7,651 $36.25 $277,349
2026-04-13 46,415 $34.76 $1,613,385
2026-04-08 1,845 $33.91 $62,564
Showing 1–18 of 18 settlements
Key facts CIK 1936258 CUSIP N62509109 13F (30d) 4 filings 3 filers Visit website Investor relations